Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tesetaxel, an advanced-generation oral taxane, as first-line treatment in women with metastatic breast cancer
    Meeting Abstract

    Schwartzberg, L. S.; Beeram, M.; Patnaik, A.; Tolcher, A. W.; Itri, L.; Olson, A. L.; Seidman, A. D.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody cixutumumab (cix) plus mTOR inhibitor temsirolimus (tem) in metastatic castration-resistant prostate cancer (mCRPC): Results of a phase I pilot study
    Meeting Abstract

    Rathkopf, D. E.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Borwick, L. S.; Momen, L.; Curley, T.; Arauz, G.; Larson, S. M.; Fleisher, M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Prevalence of hereditary GIST susceptibility in adults with GIST
    Meeting Abstract

    Rainville, I. R.; Root, E. J.; Salerno, M.; DiGianni, L.; Nelson, D. A.; Corless, C. L.; Heinrich, M. C.; Robson, M. E.; Garber, J. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • The ASCO Breast Cancer Registry pilot: Implementation of a multisite community practice registry and treatment plan/summary program
    Meeting Abstract

    Partridge, A. H.; Norris, V. W.; Blinder, V. S.; Cutter, B. A.; Halpern, M. T.; Malin, J.; Neuss, M. N.; Wolff, A. C.; ASCO Breast Cancer Registry Pilot Steering Group
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Efficacy and safety of retaspimycin hydrochloride (IPI-504) in combination with trastuzumab in patients (pts) with pretreated, locally advanced or metastatic HER2-positive breast cancer
    Meeting Abstract

    Modi, S.; Saura, C.; Henderson, C. A.; Lin, N. U.; Mahtani, R. L.; Goddard, J.; Rodenas, E.; O'Shaughnessy, J.; Baselga, J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Standardized uptake value (SUV) by positron emission tomography/computed tomography (PET/CT) as a prognostic variable in metastatic breast cancer (MBC)
    Meeting Abstract

    Morris, P. G.; Fazio, M.; Jhaveri, K. L.; Serna-Tamayo, C.; Eaton, A.; Patil, S.; Ulaner, G.; Howard, J.; Larson, S. M.; Hudis, C.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Breast cancer phenotype in women with TP53 germ-line mutations: An LFS consortium effort
    Meeting Abstract

    Masciari, S.; Dillon, D.; Dick, M. G.; Robson, M. E.; Weitzel, J. N.; Ford, J. M.; Balmana, J.; Gruber, S. B.; Euhus, D.; Garber, J. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Evaluation of response rate and disease control rate as potential predictors of overall survival in anthracycline-pretreated women receiving first-line chemotherapy for metastatic breast cancer (MBC)
    Meeting Abstract

    Liu, J.; Albain, K. S.; Chan, S.; Seidman, A. D.; Tai, D.; Wang, Y.; Zhao, L.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Risk of breast cancer (BC) after BRCA-mutation associated ovarian cancer (BRCA-OC): Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Jhaveri, K. L.; Patil, S.; Khasraw, M.; Bhatia, J.; Stadler, Z. K.; Kauff, N. D.; Hudis, C.; Offit, K.; Robson, M. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Genes regulating estradiol and estrone-conjugate levels in postmenopausal women with resected early-stage breast cancer detected by a genome-wide association study (GWAS)
    Meeting Abstract

    Ingle, J. N.; Fridley, B. L.; Buzdar, A.; Robson, M. E.; Kubo, M.; Liu, M.; Ibrahim-Zada, I.; Batzler, A.; Jenkins, G. D.; Goetz, M. P.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save